Enlightened from our previous work
of structural simplification
of quinine and innovative application of natural products against
phytopathogenic fungi, lead structure 2,8-bis(trifluoromethyl)-4-quinolinol
(3) was selected to be a candidate and its diversified
design, synthesis, and antifungal evaluation were carried out. All
of the synthesized compounds Aa1–Db1 were evaluated
for their antifungal activity against four agriculturally important
fungi, Botrytis cinerea, Fusarium graminearum, Rhizoctonia
solani, and Sclerotinia sclerotiorum. Results showed that compounds Ac3, Ac4, Ac7, Ac9, Ac12, Bb1, Bb10, Bb11, Bb13, Cb1. and Cb3 exhibited a good antifungal effect,
especially Ac12 had the most potent activity with EC50 values of 0.52 and 0.50 μg/mL against S. sclerotiorum and B. cinerea, respectively, which were more potent than those of the lead compound 3 (1.72 and 1.89 μg/mL) and commercial fungicides azoxystrobin
(both >30 μg/mL) and 8-hydroxyquinoline (2.12 and 5.28 μg/mL).
Moreover, compound Ac12 displayed excellent in
vivo antifungal activity, which was comparable in activity
to the commercial fungicide boscalid. The preliminary mechanism revealed
that compound Ac12 might cause an abnormal morphology
of cell membranes, an increase in membrane permeability, and release
of cellular contents. These results indicated that compound Ac12 displayed superior in vitro and in vivo fungicidal activities and could be a potential fungicidal
candidate against plant fungal diseases.
Based on the structural characteristics
of the cryptolepine alkaloid,
a series of new quindoline derivatives bearing various substituents
were prepared and evaluated for their fungicidal and antibacterial
activities. Bioassay results showed that compound D7 displayed
superior in vitro fungicidal activities against Sclerotinia sclerotiorum, Botrytis
cinerea, Fusarium graminearum, and Rhizoctonia solani with EC50 values of 0.780, 3.62, 1.59, and 2.85 μg/mL, respectively.
Compound A7 showed apparent antibacterial activities
toward Xanthomonas oryzae
pv.
oryzae with a minimum inhibitory concentration (MIC) value
of 3.12 μg/mL. Significantly, in vivo antifungal
activity suggested that the curative effect (98.3%) of compound D7 was comparable to that of the positive control azoxystrobin
(96.7%) at 100 μg/mL. Preliminary mechanistic studies showed
that compound D7 might cause mycelial abnormality of S. sclerotiorum, cell membrane breakage, accumulation
of reactive oxygen species (ROS), and inhibition of sclerotia formation.
Therefore, compound D7 could be a novel broad-spectrum
fungicidal candidate against plant fungal diseases.
Crop diseases caused by fungi threaten food security and exacerbate the food crisis. Inspired by the application of fungicide candidates from natural products in agrochemical discovery, a series of luotonin A derivatives were designed, synthesized, and evaluated for their antifungal activities against five plant fungi. Most of these compounds exhibited significant fungicidal activity against Botrytis cinerea in vitro with EC 50 values less than 1 μg/mL. Among them, compounds w7, w8, w12, and w15 showed superior antifungal activity against B. cinerea with EC 50 values of 0.036, 0.050, 0.042, and 0.048 μg/mL, respectively, which were more potent than boscalid (EC 50 = 1.790 μg/mL). Preliminary mechanism studies revealed that compound w7 might pursue its antifungal activity by disrupting the fungal cell membrane and cell wall. Moreover, in vivo bioassay also indicated that compound w7 could be effective for the control of B. cinerea. The above results evidenced the potential of luotonin A derivatives as novel and promising candidate fungicides.
Rhizoctonia solani causes serious plant diseases.
Neocryptolepine presented the significant antifungal activity against R. solani, however the mode of action is
unclear. In this paper, we investigated the potential mode of action
of neocryptolepine against R. solani integrated the proteomics and transcriptomics. Results showed that
after treatment with neocryptolepine, 1012 differentially expressed
proteins and 10 920 differentially expressed genes of R. solani were found, most of them were
enriched in mitochondrial respiratory chain. It affected oxidative
phosphorylation led to the enrichment of ROS and the decrease of MMP,
and inhibited complex III activity with the inhibition rate of 63.51%
at 10 μg/mL. The mitochondrial structural and function were
damaged. Cytochrome b-c1 complex subunit Rieske (UQCRFS1)
with the high binding score to neocryptolepine was found as a potential
target. In addition, it inhibited the sclerotia formation and presented
antifungal efficacy by decreasing the diameter of a wound in potato
in a concentration-dependent manner. Above results indicated that
neocryptolepine inhibited the complex III activity by binding UQCRFS1
and blocked the ion transfer to cause the death of R. solani mycelia. This study laid the foundation
for the future development of neocryptolepine as an alternative biofungicide.
The increasing resistance of plant diseases caused by phytopathogenic fungi highlights the need for highly effective and environmentally benign agents. The antifungal activities of Cnidium monnieri fruit extracts and five isolated compounds as well as structurally related coumarins against five plant pathogenic fungi were evaluated. The acetone extract, which contained the highest amount of five coumarins, showed strongest antifungal activity. Among the coumarin compounds, we found that 4-methoxycoumarin exhibited stronger and broader antifungal activity against five phytopathogenic fungi, and was more potent than osthol. Especially, it could significantly inhibit the growth of Rhizoctonia solani mycelium with an EC 50 value of 21 μg mL À 1 . Further studies showed that 4-methoxycoumarin affected the structure and function of peroxisomes, inhibited the β-oxidation of fatty acids, decreased the production of ATP and acetyl coenzyme A, and then accumulated ROS by damaging MMP and the mitochondrial function to cause the cell death of R. solani mycelia. 4-Methoxycoumarin presented antifungal efficacy in a concentration-dependent manner in vivo and could be used to prevent the potato black scurf. This study laid the foundation for the future development of 4-methoxycournamin as an alternative and friendly biofungicide.
Humulus lupulus Linn. is a traditional medicinal and edible plant with several biological properties. The aims of this work were: (1) to evaluate the in vitro antifungal activity of H. lupulus ethanolic extract; (2) to study the in vitro and in vivo antifungal activity of isoxanthohumol, an isoprene flavonoid from H. lupulus, against Botrytis cinerea; and (3) to explore the antifungal mechanism of isoxanthohumol on B. cinerea. The present data revealed that the ethanolic extract of H. lupulus exhibited moderate antifungal activity against the five tested phytopathogenic fungi in vitro, and isoxanthohumol showed highly significant antifungal activity against B. cinerea, with an EC50 value of 4.32 µg/mL. Meanwhile, it exhibited moderate to excellent protective and curative efficacies in vivo. The results of morphologic observation, RNA-seq, and physiological indicators revealed that the antifungal mechanism of isoxanthohumol is mainly related to metabolism; it affected the carbohydrate metabolic process, destroyed the tricarboxylic acid (TCA) cycle, and hindered the generation of ATP by inhibiting respiration. Further studies indicated that isoxanthohumol caused membrane lipid peroxidation, thus accelerating the death of B. cinerea. This study demonstrates that isoxanthohumol can be used as a potential botanical fungicide for the management of phytopathogenic fungi.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.